Patient Impacts
Biotechnology is delivering for patients around the world:
- More than 7.6 billion people treated by a biotechnology drug in 2024
- Massachusetts makes up 16.1% of the U.S. drug development pipeline…
- …and 6.4% of the global pipeline
- There are between 6,000 and 8,000 active clinical trials in Massachusetts
- In 2025, 28 companies with Massachusetts ties received FDA approvals
Economic Growth
The life sciences have delivered outsized impact to Massachusetts:
- $42 billion 2024 GDP contribution
- 117,000 biopharma jobs in 2024
- 26% of all VC dollars invested in the US biopharma industry came to Massachusetts
- Eleven Massachusetts cities/towns had at least 1% of VC dollars
Watch:
This is the place for the world.
This is the place for patients.
This is the place for believers.
This is the place with the full stack.
This is the place.
This is the place: Pioneers of Biotech
Learn:
Innovation
Massachusetts’s dynamic life sciences innovation ecosystem thrives on transformative science and powerful partnerships. MassBio convenes, connects, and catalyzes the ecosystem, serving as a platform to source, accelerate, partner, and fund innovation.
2025 Industry Snapshot
We are pleased to share with you the 2025 MassBio Industry Snapshot. This annual report tracks the Massachusetts life sciences industry’s growth, including employment, industry investment, drug development pipeline, real estate, and regionalization metrics.
2025 Biopharma Funding & Pipeline Report
The 2025 Biopharma Funding & Pipeline Report includes full-year data on venture capital investment, IPOs, and mergers & acquisitions, as well as drug pipeline statistics and FDA approvals.
Economic Development
MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Commonwealth. We make Massachusetts a better place for your business.